- Home
- OSCR vs TVTX Comparison
OSCR vs TVTX Comparison
Compare OSCR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSCR | TVTX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | OSCR | TVTX |
|---|---|---|
| Price | $25.53 | $42.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $16.88 | ★ $40.62 |
| AVG Volume (30 Days) | ★ 7.3M | 2.1M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.89 |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $11,701,427,000.00 | N/A |
| Revenue This Year | $63.89 | $44.76 |
| Revenue Next Year | $5.30 | $35.51 |
| P/E Ratio | $11.19 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $10.69 | $13.88 |
| 52 Week High | $24.28 | $48.61 |
Technical Indicators
Market Signals| Indicator | OSCR | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 85.64 | 58.53 |
| Support Level | $12.18 | $41.55 |
| Resistance Level | N/A | $48.61 |
| Average True Range (ATR) | 1.32 | 2.34 |
| MACD | 0.43 | -0.45 |
| Stochastic Oscillator | 99.62 | 35.84 |
Price Performance
Historical ComparisonAbout OSCR Oscar Health Inc.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.